Michael Chi, the Chief Operating Officer of $HIMS, sold 14,027 shares of the company on 06-17-2026 for an estimated $441,850. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1% of their shares of this class of stock. Following this trade, they now own 432,124 shares of this class of $HIMS stock.
$HIMS Insider Trading Activity
$HIMS insiders have traded $HIMS stock on the open market 24 times in the past 6 months. Of those trades, 1 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:
- OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 10 sales selling 142,203 shares for an estimated $4,077,695.
- MICHAEL CHI (Chief Operating Officer) has made 0 purchases and 3 sales selling 125,066 shares for an estimated $3,348,678.
- DAVID B WELLS purchased 48,400 shares for an estimated $1,172,974
- MOHAMED ELSHENAWY (CTO) sold 30,040 shares for an estimated $946,260
- IRENE BECKLUND (PAO) has made 0 purchases and 4 sales selling 26,003 shares for an estimated $815,797.
- SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 3 sales selling 18,926 shares for an estimated $473,439.
- PATRICK HARRISON CARROLL (Chief Medical Officer) sold 10,021 shares for an estimated $367,870
- DEBORAH M. AUTOR (Chief Policy Officer) sold 7,054 shares for an estimated $258,952
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$HIMS Hedge Fund Activity
We have seen 230 institutional investors add shares of $HIMS stock to their portfolio, and 369 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 14,322,912 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $297,343,653
- FORERUNNER VENTURES MANAGEMENT, LLC removed 9,756,893 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $316,806,315
- GOLDMAN SACHS GROUP INC removed 7,892,648 shares (-76.3%) from their portfolio in Q1 2026, for an estimated $163,851,372
- DEFIANCE ETFS, LLC added 7,424,258 shares (+inf%) to their portfolio in Q1 2026, for an estimated $154,127,596
- MORGAN STANLEY added 4,959,856 shares (+126.2%) to their portfolio in Q1 2026, for an estimated $102,966,610
- FARALLON CAPITAL MANAGEMENT LLC removed 3,376,986 shares (-99.7%) from their portfolio in Q1 2026, for an estimated $70,106,229
- BANK OF AMERICA CORP /DE/ added 2,877,550 shares (+194.4%) to their portfolio in Q1 2026, for an estimated $59,737,938
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$HIMS Revenue
$HIMS had revenues of $608.1M in Q1 2026. This is an increase of 3.77% from the same period in the prior year.
You can track HIMS financials on Quiver Quantitative's HIMS stock page.
You can access data on HIMS stock through the Quiver Quantitative API.
$HIMS Price Targets
Multiple analysts have issued price targets for $HIMS recently. We have seen 12 analysts offer price targets for $HIMS in the last 6 months, with a median target of $26.5.
Here are some recent targets:
- Allen Lutz from B of A Securities set a target price of $25.0 on 05/26/2026
- Jailendra Singh from Truist Securities set a target price of $23.0 on 05/22/2026
- Ryan MacDonald from Needham set a target price of $35.0 on 05/12/2026
- Cory Carpenter from JP Morgan set a target price of $33.0 on 05/12/2026
- Daniel Grosslight from Citigroup set a target price of $28.0 on 05/12/2026
- Jonna Kim from TD Cowen set a target price of $23.0 on 03/27/2026
- Michael Cherny from Leerink Partners set a target price of $25.0 on 03/16/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
